UWA invests $1m in OncoRes Medical, as company enters final stretch of FDA pitch
The University of Western Australia has invested $1 million into Perth-based medtech company OncoRes. The investment is UWA’s first in one of its 25 spinout companies.OncoRes chief executive Dr Katharine Giles said the investment would be welcomed as it moves towards potential US Food and Drug Administration approval of its Elora precision cancer imaging technology.
